FDA to Tap Online Patient Forum for Drug Safety Issues

The FDA plans to mine data submitted by patients on the site PatientsLikeMe.

The FDA, in an attempt to gather post-marketing data directly from the source, is planning to access data submitted on the patient-networking website PatientsLikeMe. The hope is to collect data that patients submit on drug-use experiences, symptoms, and hospitalizations.

The project is currently in its exploratory phase. “We’re hoping we can find information on the impact of adverse events on patients’ day-to-day lives,” said Gerald Dal Pan, director of the Office of Surveillance and Epidemiology at the FDA, in a statement.

Read more on Bloomberg News: http://bloom.bg/1Laqub8